N-ACCIL-(3-SUSUSUSTA)-(8-SUSUACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACMETHOD(S) OF ADMINISTRATION FROM SUBJECT NK-3 DIRECTIVES

摘要

This invention concerns novel compounds of the type (I) and their use in therapeutic treatments.